Cite
HARVARD Citation
Gigoux, M. et al. (n.d.). 444 MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination. Journal for immunotherapy of cancer. p. A470. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gigoux, M. et al. (n.d.). 444 MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination. Journal for immunotherapy of cancer. p. A470. [Online].